Scott Moore explores China’s trajectory in the global biotechnology sector. When America has become the dominant world wide player in creating and commercializing biotechnology for decades, China is decided to be a number one participant in biotechnology and is particularly investing seriously in the sector. Moore argues that, whilst the U.S. is